Dr. Gabor Racz invites you to attend
the ASIPP 23rd Annual Meeting,
June 24-26 in NOLA!
Take advantage of this opportunity to hear the Raj/Racz Distinguished Lecture Series in honor of these two great leaders in interventional pain management.
|
|
Topics will include COVID-19, ECONOMICS, BURNOUT, SOCIAL MEDIA, METABOLIC HEALTH, REGULATORY ISSUES, SCIENTIFIC ADVANCES in IPM, and MUCH MORE!
|
|
The ASIPP Annual Meeting will feature
THREE INNOVATION SUMMITS during the afternoon breakout sessions each day.
Learn about the
LATEST TECHNOLOGICAL ADVANCEMENTS
to help you in your practice.
Multiple technologies will be highlighted in the areas of SPINAL CORD STIMULATION,
PERIPHERAL NERVE STIMULATION, and
MINIMALLY INVASIVE TECHNOLOGIES.
|
|
Researchers from England examined effectiveness of Pfizer, AstraZeneca vaccines
Both the Pfizer and AstraZeneca COVID-19 vaccines showed effectiveness against symptomatic disease from B.1.617.2, the so-called Indian variant, British researchers found.
Two doses of Pfizer's vaccine showed 87.9% efficacy (95% CI 78.2%-93.2%) against the variant, while two doses of AstraZeneca's showed 59.8% efficacy (95% CI 28.9%-77.3%), reported Jamie Lopez Bernal, PhD, of Public Health England in London, and colleagues in a preprint manuscript online.
Vaccine effectiveness after one dose against B.1.617.2 was similarly low for both vaccines, at 33%.
|
|
One-fourth of physicians report being personally attacked on social media, with many experiencing death threats, verbal abuse, and sharing of personally identifying information, according to a new study.
Additionally, one in six female physicians reported online sexual harassment.
|
|
Report says researchers went to hospital in November 2019, shortly before confirming outbreak; adds to calls for probe of whether virus escaped lab
Three researchers from China’s Wuhan Institute of Virology became sick enough in November 2019 that they sought hospital care, according to a previously undisclosed U.S. intelligence report that could add weight to growing calls for a fuller probe of whether the Covid-19 virus may have escaped from the laboratory.
The details of the reporting go beyond a State Department fact sheet, issued during the final days of the Trump administration, which said that several researchers at the lab, a center for the study of coronaviruses and other pathogens, became sick in autumn 2019 “with symptoms consistent with both Covid-19 and common seasonal illness.”
|
|
A number of questions have recently arisen about how we should negotiate a social and professional world in which vaccination against Covid-19 is both common and contested. What’s clear is that many people think that getting vaccinated is simply about protecting yourself. And we do have what a philosopher would call a reason of prudence for getting vaccinated — a reason that’s more compelling the older we are. Yet there’s also a public-spirited, altruistic reason for getting vaccinated: There’s now bountiful evidence that vaccinated people are much less likely to transmit the virus to others.
|
|
Scientists have to stop believing that we'll change minds with more data, adds president & CEO
Scientists and clinicians need to work to rebuild trust in the healthcare system, according to officials from the American Board of Internal Medicine (ABIM) Foundation.
"We really are living in a world in which facts themselves -- the whole existence of facts -- is in dispute," said Richard Baron, MD, president and CEO of the foundation, at an event last week to launch the foundation's Building Trust initiative. "How do we explain the number of people in the country who are just not interested in that COVID vaccine, or who are turning away from pretty established science? ... The scale on which we're seeing that suggests a major politicization of knowledge."
|
|
55-44 vote was mostly along party lines
The Senate voted 55-44 Tuesday to confirm Chiquita Brooks-LaSure as administrator of the Centers for Medicare & Medicaid Services (CMS).
Nominations for a position like CMS administrator are not usually controversial, but these are unusual times. Sen. John Cornyn (R-Texas) explained on the Senate floor Monday that he would vote against Brooks-LaSure not because she wasn't qualified, but because "the Biden administration has taken the unprecedented step of rescinding an agreement with my state and the previous administration to maintain the stability of our state's Medicaid program."
|
|
Pain Medicine Case Reports (PMCR) and Editor-in-Chief Alaa Abd-Elsayed, MD, PhD would like to invite you to submit case reports and case series to the PMCR journal. Your article will be published free of charge.
Open access journals are freely available online for immediate worldwide open access to the full text of published articles. There is no subscription fee for open access journals. Open access journals are no different from traditional subscription-based journals: they undergo the same peer-review and quality control as any other scholarly journal.
Interested in becoming a member of the PMCR Editorial Board?
Editorial board members are asked to review 2-6 manuscripts per year. Please submit your most up-to-date CV to sgold@asipp.org for consideration.
For more information or to submit your articles, click here.
|
|
| CASE REPORT |
Ky Raymond, DO, and Michael McKenna, MD
Abstract
BACKGROUND: Neurolytic celiac plexus blocks can effectively ameliorate intractable epigastric pain caused by intraabdominal cancers. Multiple techniques have been described, including transaortic and transdiscal needle placement. The authors have preferred the single needle transaortic fluoroscopically-guided technique owing to the reproducible anatomic landmarks for needle tip placement within the anterior periaortic space at the midline of the T12-L1 spinal segment.
CASE REPORT: A 70-year old man with intractable localized epigastric pain from stage IV adenocarcinoma of the stomach was referred for consideration of a neurolytic celiac plexus block. The abdominal computed tomography scan revealed a noncalcified abdominal aorta that was centrally located at the T12-L1 level. Face validity correlates optimal anatomic needle placement and the resultant minimal neurolytic injectate volume with maximal efficacy and minimal side effects. While specific fluoroscopic images guide needle track and depth, tactile sensations and blood return provide physiological confirmation of needle tip location. A characteristic contrast pattern confirms attainment of the anatomic target. We discuss a novel technique—a single needle transdiscal, transaortic approach—for celiac plexus neurolysis in a patient with atypical abdominal aortic anatomy.
|
|
| PROSPECTIVE STUDY |
Christopher Centeno, MD, Cameron Cartier, DO, Ian Stemper, MS, Ehren Dodson, PhD, Michael Freeman, MD, PhD, Ugochi Azuike, DO, Christopher Williams, MD, Matthew Hyzy, DO, Otono Silva, MD,
and Neven Steinmetz, PhD
Abstract
BACKGROUND: Bone marrow lesions are a radiographic indication of bony pathology closely associated with advanced osteoarthritis of the adjacent joint. Injection of autologous orthobiologic products, including bone marrow concentrate and platelet-rich plasma, have demonstrated safety and efficacy in treating both advanced osteoarthritis (via intraarticular injection) and associated bone marrow lesions (via intraosseous injection). The relative efficacy of intraarticular versus intraosseous injection of orthobiologics has not been evaluated at the present time.
OBJECTIVES: The objective was to evaluate differences in orthobiologic bone marrow lesions treatment, either as a collateral result of intraarticular injection with bone marrow concentrate and platelet products alone, or intraosseous plus intraarticular injection as measured by patient reported outcomes.
|
|
| DELPHI PANEL STUDY |
Christopher J. Centeno, MD, Mairin A. Jerome, MD,
Sarah M. Pastoriza, DO, Shane Shapiro, MD, Ken Mautner, MD, Gerard A. Malanga, MD, Michael J. DePalma, MD,
R. Amadeus Mason, MD, Ian Stemper, MS, and Ehren Dodson, PhD
Abstract
BACKGROUND: Acute and degenerative musculoskeletal disorders are among the most common etiologies of disability worldwide. Recently, there has been interest in the field of regenerative medicine to bridge the gap between conservative and surgical management of these conditions. Autologous bone marrow concentrate is one type of injectate that has increased in popularity over the last few decades. Though there is promising evidence supporting its efficacy, standard of care practice guidelines to govern the appropriate use and implementation of such technology are currently lacking.
OBJECTIVES: The aim of this article is to report findings from a survey administered using the Delphi technique to a group of physicians using bone marrow concentrate in practice to determine best practice consensus regarding optimization of patient safety and education.
|
|
Since this malpractice insurance program officially launched in November 2018, ASIPP has signed up hundreds of providers with an average savings of 30%. This is professional liability insurance tailored to our specialty and will stand up for us and defend our practices.
Norcal Mutual is 'A' Rated by AM best and is license in all 50 states. To read a few important points to keep in mind about the program, including discounts, administrative defense, cyber coverage, aggressive claims handling, and complimentary award-winning risk management CME activities, click here.
|
|
ASIPP® is now offering our members the benefit of a unique revenue cycle management/ billing service. We have received a tremendous amount of interest in the ASIPP® billing and coding program.
Click here to learn more about the negotiated rate for practices and more!
|
ASIPP® has formed a partnership with Henry Schein and PedsPal, a national GPO that has a successful history of negotiating better prices on medical supplies and creating value-added services for the independent physician. Working with MedAssets, PedsPal provides excellent pricing on products like contrast media that alleviate some of the financial pressures you experience today.
|
|
up-to-date news related to you, your practice, and your patients!
|
|
|
|
|
|
|
